PT-141, also known as bremelanotide, is a synthetic heptapeptide analog of the naturally occurring α-melanocyte-stimulating hormone (α-MSH). At the molecular level, PT-141 functions as a non-selective agonist for melanocortin receptors, exhibiting a strong binding affinity for the MC3R and MC4R subtypes. In experimental laboratory settings, this peptide is primarily utilized to investigate melanocortin signaling cascades and the subsequent intracellular accumulation of cyclic AMP (cAMP). In vitro research frequently employs PT-141 compounds to explore receptor binding kinetics, neuroendocrine signaling networks, and fundamental biochemical responses associated with melanocortin receptor activation in isolated cellular models.